Janus Henderson Group
AXSM icon

Janus Henderson Group’s Axsome Therapeutics AXSM Stock Holding History

Janus Henderson Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.22M Buy
19,052
+3,948
+26% +$682K ﹤0.01% 1129
2025
Q4 		$2.76M Hold
15,104
– – ﹤0.01% 1176
2025
Q3 		$1.83M Buy
15,104
+1,104
+8% +$124K ﹤0.01% 1368
2025
Q2 		$1.46M Hold
14,000
– – ﹤0.01% 1426
2025
Q1 		$1.66M Hold
14,000
– – ﹤0.01% 1376
2024
Q4 		$1.18M Hold
14,000
– – ﹤0.01% 1603
2024
Q3 		$1.26M Hold
14,000
– – ﹤0.01% 1551
2024
Q2 		$1.13M Sell
14,000
-188
-1% -$13.9K ﹤0.01% 1563
2024
Q1 		$1.13M Buy
14,188
+1
+0% +$84 ﹤0.01% 1575
2023
Q4 		$1.13M Sell
14,187
-28
-0.2% -$1.87K ﹤0.01% 1562
2023
Q3 		$993K Buy
14,215
+12
+0.1% +$897 ﹤0.01% 1559
2023
Q2 		$1.02M Sell
14,203
-21
-0.1% -$1.55K ﹤0.01% 1605
2023
Q1 		$877K Buy
14,224
+9,256
+186% +$608K ﹤0.01% 1711
2022
Q4 		$383K Hold
4,968
– – ﹤0.01% 1853
2022
Q3 		$222K Buy
+4,968
New +$248K ﹤0.01% 2357
2022
Q2 		– Sell
-4,958
Closed -$205K – 2600
2022
Q1 		$205K Buy
+4,958
New +$154K ﹤0.01% 2427
2021
Q2 		– Sell
-211,581
Closed -$12M – 1613
2021
Q1 		$12M Sell
211,581
-237,072
-53% -$16.7M 0.01% 867
2020
Q4 		$36.6M Sell
448,653
-66,230
-13% -$4.95M 0.02% 623
2020
Q3 		$36.7M Sell
514,883
-6,268
-1% -$488K 0.02% 569
2020
Q2 		$42.9M Buy
+521,151
New +$40.1M 0.02% 525

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group's AXSM Position: Q1 2026 in Review

Janus Henderson Group increased its Axsome Therapeutics (AXSM) stake by 26% in Q1 2026, buying an estimated $682K and bringing the position to 19,052 shares worth $3.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

Janus Henderson Group first reported a position in AXSM in Q2 2020 and has held it in 20 quarters since. The position peaked at $42.9M in Q2 2020. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Janus Henderson Group held 19,052 shares of Axsome Therapeutics worth $3.22M as of Q1 2026.
  • Janus Henderson Group bought 3,948 Axsome Therapeutics shares in Q1 2026, an estimated $682K.
  • Axsome Therapeutics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1129 holding.
  • Janus Henderson Group first reported a position in Axsome Therapeutics in Q2 2020 and has held it in 20 quarters since.
  • Janus Henderson Group's Axsome Therapeutics position peaked at $42.9M in Q2 2020.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.